Implicit Bioscience

Leveraging products and finance to reduce risk and improve outcomes for patients and shareholders.

IMPLICIT APPOINTS HELEN ROBERTS TO LEAD BUSINESS DEVELOPMENT

01 December 2007

Implicit Bioscience has appointed Helen Roberts as Director of Business Development. Helen brings to Implicit over 18 years experience in the biotechnology and pharmaceutical sector...

21 October 2007

Implicit Bioscience announced today that it has been awarded a US16.34 million (AU$18.2million) contract payable over 37 months from the United States Defense Threat Reduction Agency (DTRA) to develop its clinical-stage drug oglufanide disodium as a broad spectrum therapeutic...

24 August 2007

Physicians at Southern Health have started a phase IIa clinical trial designed to test the efficacy of a new strategy for defeating hepatitis C viral infection, ...

22 March 2007
Timothy Axtelle has been appointed as Vice President, Research and Development of Implicit Bioscience Pty Ltd